190 related articles for article (PubMed ID: 38266129)
21. Competitive interaction between chronic obstructive pulmonary disease and CHA
Perticone M; Sciacqua A; Tripepi G; Miceli S; Corrao S; Sesti G; Perticone F
Int J Cardiol; 2018 Mar; 255():74-79. PubMed ID: 29174184
[TBL] [Abstract][Full Text] [Related]
22. Antithrombotic treatment for newly diagnosed atrial fibrillation in relation to patient age: the GLORIA-AF registry programme.
Mazurek M; Halperin JL; Huisman MV; Diener HC; Dubner SJ; Ma CS; Rothman KJ; Healey JS; Teutsch C; Paquette M; França LR; Lu S; Bartels DB; Lip GYH
Europace; 2020 Jan; 22(1):47-57. PubMed ID: 31651951
[TBL] [Abstract][Full Text] [Related]
23. Clinical Characteristics, Oral Anticoagulation Patterns, and Outcomes of Medicaid Patients With Atrial Fibrillation: Insights From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF I) Registry.
O'Brien EC; Kim S; Thomas L; Fonarow GC; Kowey PR; Mahaffey KW; Gersh BJ; Piccini JP; Peterson ED
J Am Heart Assoc; 2016 May; 5(5):. PubMed ID: 27146448
[TBL] [Abstract][Full Text] [Related]
24. Symptom Status, Clinical Subtypes, and Prognosis in Patients With Atrial Fibrillation from the Middle East Region (from the Gulf-SAFE Registry).
Xie PX; Li YG; Alsheikh-Ali AA; AlMahmeed W; Shehab A; Sulaiman K; Asaad N; Guo LJ; Liu SW; Zubaid M; Lip GYH
Am J Cardiol; 2022 Apr; 169():57-63. PubMed ID: 35063269
[TBL] [Abstract][Full Text] [Related]
25. Impact of early ablation of atrial fibrillation on long-term outcomes: results from phase II/III of the GLORIA-AF registry.
Ding WY; Calvert P; Gupta D; Huisman MV; Lip GYH;
Clin Res Cardiol; 2022 Sep; 111(9):1057-1068. PubMed ID: 35488127
[TBL] [Abstract][Full Text] [Related]
26. Patterns of oral anticoagulant use and outcomes in Asian patients with atrial fibrillation: a post-hoc analysis from the GLORIA-AF Registry.
Romiti GF; Corica B; Proietti M; Mei DA; Frydenlund J; Bisson A; Boriani G; Olshansky B; Chan YH; Huisman MV; Chao TF; Lip GYH;
EClinicalMedicine; 2023 Sep; 63():102039. PubMed ID: 37753446
[TBL] [Abstract][Full Text] [Related]
27. Global Oral Anticoagulation Use Varies by Region in Patients With Recent Diagnosis of Atrial Fibrillation: The GLORIA-AF Phase III Registry.
Bayer V; Kotalczyk A; Kea B; Teutsch C; Larsen P; Button D; Huisman MV; Lip GYH; Olshansky B
J Am Heart Assoc; 2022 Mar; 11(6):e023907. PubMed ID: 35243870
[TBL] [Abstract][Full Text] [Related]
28. CHA2DS2-VASc score for ischaemic stroke risk stratification in patients with chronic obstructive pulmonary disease with and without atrial fibrillation: a nationwide cohort study.
Hu WS; Lin CL
Europace; 2018 Apr; 20(4):575-581. PubMed ID: 28407109
[TBL] [Abstract][Full Text] [Related]
29. Improved outcomes with European Society of Cardiology guideline-adherent antithrombotic treatment in high-risk patients with atrial fibrillation: a report from the EORP-AF General Pilot Registry.
Lip GY; Laroche C; Popescu MI; Rasmussen LH; Vitali-Serdoz L; Dan GA; Kalarus Z; Crijns HJ; Oliveira MM; Tavazzi L; Maggioni AP; Boriani G
Europace; 2015 Dec; 17(12):1777-86. PubMed ID: 26321406
[TBL] [Abstract][Full Text] [Related]
30. Factors associated with non-fatal heart failure and atrial fibrillation or flutter within the first 30 days post COPD exacerbation: a nested case-control study.
Graul EL; Nordon C; Rhodes K; Menon S; Al Ammouri M; Kallis C; Ioannides AE; Whittaker HR; Peters NS; Quint JK
BMC Pulm Med; 2024 May; 24(1):221. PubMed ID: 38704538
[TBL] [Abstract][Full Text] [Related]
31. Potential Augmentation of the Risk of Ischemic Cerebrovascular Accident by Chronic Obstructive Pulmonary Disease in Patients with Atrial Fibrillation.
Nadeem R; Sharieff A; Tanna S; Sidhu H; Molnar J; Nadeem A
J Stroke Cerebrovasc Dis; 2015 Aug; 24(8):1893-6. PubMed ID: 26142261
[TBL] [Abstract][Full Text] [Related]
32. Risks and benefits of anticoagulation in atrial fibrillation: insights from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry.
Cullen MW; Kim S; Piccini JP; Ansell JE; Fonarow GC; Hylek EM; Singer DE; Mahaffey KW; Kowey PR; Thomas L; Go AS; Lopes RD; Chang P; Peterson ED; Gersh BJ;
Circ Cardiovasc Qual Outcomes; 2013 Jul; 6(4):461-9. PubMed ID: 23759473
[TBL] [Abstract][Full Text] [Related]
33. Adherence to the "Atrial fibrillation Better Care" (ABC) pathway in patients with atrial fibrillation and cancer: A report from the ESC-EHRA EURObservational Research Programme in atrial fibrillation (EORP-AF) General Long-Term Registry.
Vitolo M; Proietti M; Malavasi VL; Bonini N; Romiti GF; Imberti JF; Fauchier L; Marin F; Nabauer M; Potpara TS; Dan GA; Kalarus Z; Maggioni AP; Lane DA; Lip GYH; Boriani G;
Eur J Intern Med; 2022 Nov; 105():54-62. PubMed ID: 36028394
[TBL] [Abstract][Full Text] [Related]
34. Effectiveness, safety, and major adverse limb events in atrial fibrillation patients with concomitant diabetes mellitus treated with non-vitamin K antagonist oral anticoagulants.
Chan YH; Lee HF; Li PR; Liu JR; Chao TF; Wu LS; Chang SH; Yeh YH; Kuo CT; See LC; Lip GYH
Cardiovasc Diabetol; 2020 May; 19(1):63. PubMed ID: 32404168
[TBL] [Abstract][Full Text] [Related]
35. Current Status, Time Trends and Outcomes of Combination Therapy With Oral Anticoagulant and Antiplatelet Drug in Patients With Atrial Fibrillation - The Fushimi AF Registry.
Masunaga N; Abe M; Ogawa H; Aono Y; Ikeda S; Doi K; An Y; Ishii M; Iguchi M; Esato M; Tsuji H; Wada H; Hasegawa K; Lip GYH; Akao M;
Circ J; 2018 Nov; 82(12):2983-2991. PubMed ID: 30381701
[TBL] [Abstract][Full Text] [Related]
36. Outcomes Associated With Oral Anticoagulants Plus Antiplatelets in Patients With Newly Diagnosed Atrial Fibrillation.
Fox KAA; Velentgas P; Camm AJ; Bassand JP; Fitzmaurice DA; Gersh BJ; Goldhaber SZ; Goto S; Haas S; Misselwitz F; Pieper KS; Turpie AGG; Verheugt FWA; Dabrowski E; Luo K; Gibbs L; Kakkar AK;
JAMA Netw Open; 2020 Feb; 3(2):e200107. PubMed ID: 32101311
[TBL] [Abstract][Full Text] [Related]
37. Bleeding and ischaemic events after first bleed in anticoagulated atrial fibrillation patients: risk and timing.
Meyre PB; Blum S; Hennings E; Aeschbacher S; Reichlin T; Rodondi N; Beer JH; Stauber A; Müller A; Sinnecker T; Moutzouri E; Paladini RE; Moschovitis G; Conte G; Auricchio A; Ramadani A; Schwenkglenks M; Bonati LH; Kühne M; Osswald S; Conen D
Eur Heart J; 2022 Dec; 43(47):4899-4908. PubMed ID: 36285887
[TBL] [Abstract][Full Text] [Related]
38. Incidence of Stroke or Systemic Embolism in Paroxysmal Versus Sustained Atrial Fibrillation: The Fushimi Atrial Fibrillation Registry.
Takabayashi K; Hamatani Y; Yamashita Y; Takagi D; Unoki T; Ishii M; Iguchi M; Masunaga N; Ogawa H; Esato M; Chun YH; Tsuji H; Wada H; Hasegawa K; Abe M; Lip GY; Akao M
Stroke; 2015 Dec; 46(12):3354-61. PubMed ID: 26514188
[TBL] [Abstract][Full Text] [Related]
39. Changes to oral anticoagulant therapy and risk of death over a 3-year follow-up of a contemporary cohort of European patients with atrial fibrillation final report of the EURObservational Research Programme on Atrial Fibrillation (EORP-AF) pilot general registry.
Boriani G; Proietti M; Laroche C; Diemberger I; Popescu MI; Riahi S; Shantsila A; Dan GA; Tavazzi L; Maggioni AP; Lip GYH;
Int J Cardiol; 2018 Nov; 271():68-74. PubMed ID: 30001945
[TBL] [Abstract][Full Text] [Related]
40. Outcomes of anticoagulated patients with atrial fibrillation treated with or without antiplatelet therapy - A pooled analysis from the PREFER in AF and PREFER in AF PROLONGATON registries.
Patti G; Pecen L; Lucerna M; Huber K; Rohla M; Renda G; Siller-Matula J; Schnabel RB; Cemin R; Kirchhof P; De Caterina R
Int J Cardiol; 2018 Nov; 270():160-166. PubMed ID: 30220376
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
